ArticleCureus2026
Sacral Chordoma: Multimodality Imaging and Radiologic-Pathologic Correlation of a Rare Malignant Sacral Tumor.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chordoma is a rare malignant tumor arising from embryonic notochordal remnants and most commonly involves the sacrococcygeal region. Because of its slow-growing nature and nonspecific clinical presentation, diagnosis is often delayed until significant local extension occurs. Imaging plays a crucial role in lesion detection, characterization, and surgical planning. We report a case of sacral chordoma in a 63-year-old woman presenting with chronic sacral pain and constipation. Initial radiographs were subtle, demonstrating non-visualization of the distal sacral segments and ill-defined sacral soft tissue fullness. CT revealed a large destructive lytic lesion involving the sacrum from S2 to the distal sacrococcygeal segments with internal chunky calcifications, sacral canal involvement, and bulky presacral extension. MRI demonstrated a lobulated mass with iso- to hypointense T1 signal, heterogeneous T2/short TI inversion recovery (STIR) hyperintensity, diffusion restriction, and avid heterogeneous enhancement with central non-enhancing areas. Histopathology confirmed chordoma with characteristic physaliphorous cells embedded in a myxoid stroma. This case highlights the characteristic multimodality imaging appearance of sacral chordoma and emphasizes the importance of radiologic-pathologic correlation in establishing diagnosis and narrowing the differential considerations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.